Cargando…

Elevated N6-Methyladenosine RNA Levels in Peripheral Blood Immune Cells: A Novel Predictive Biomarker and Therapeutic Target for Colorectal Cancer

Effective biomarkers for the diagnosis of colorectal cancer (CRC) are essential for improving prognosis. Imbalance in regulation of N6-methyladenosine (m(6)A) RNA has been associated with a variety of cancers. However, whether the m(6)A RNA levels of peripheral blood can serve as a diagnostic biomar...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xie, Jinye, Huang, Zhijian, Jiang, Ping, Wu, Runan, Jiang, Hongbo, Luo, Chuanghua, Hong, Honghai, Yin, Haofan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8515146/ https://www.ncbi.nlm.nih.gov/pubmed/34659267 http://dx.doi.org/10.3389/fimmu.2021.760747

Ejemplares similares

5-Methylcytosine (m(5)C) modification in peripheral blood immune cells is a novel non-invasive biomarker for colorectal cancer diagnosis
por: Yin, Haofan, et al.
Publicado: (2022)

N(6)-Methyladenosine in Cancer Immunotherapy: An Undervalued Therapeutic Target
por: Quan, Chao, et al.
Publicado: (2021)

Adipose triglyceride lipase promotes the proliferation of colorectal cancer cells via enhancing the lipolytic pathway
por: Yin, Haofan, et al.
Publicado: (2021)

N(6) -Methyladenosine and Rheumatoid Arthritis: A Comprehensive Review
por: Wu, Sha, et al.
Publicado: (2021)

Diagnostic value of aberrant decreased 5-Methylcytosine RNA modification in leukocytes for non-small cell lung cancer
por: Huang, Mao, et al.
Publicado: (2023)

N6-methyladenosine-methylomic landscape of lung tissues of mice with chronic obstructive pulmonary disease
por: Hu, Tingting, et al.
Publicado: (2023)

N(6)-Methyladenosine regulator RBM15B acts as an independent prognostic biomarker and its clinical significance in uveal melanoma
por: Wang, Tianyu, et al.
Publicado: (2022)

Multi-omics analysis of N6-methyladenosine reader IGF2BP3 as a promising biomarker in pan-cancer
por: Chen, Pin, et al.
Publicado: (2023)

Comprehensive of N1-Methyladenosine Modifications Patterns and Immunological Characteristics in Ovarian Cancer
por: Liu, Jinhui, et al.
Publicado: (2021)

The Non-N(6)-Methyladenosine Epitranscriptome Patterns and Characteristics of Tumor Microenvironment Infiltration and Mesenchymal Transition in Glioblastoma
por: Xu, Jianye, et al.
Publicado: (2022)

N (6)-Methyladenosine Methylomic Landscape of Lung Tissues in Murine Acute Allergic Asthma
por: Teng, Fangzhou, et al.
Publicado: (2021)

N6-Methyladenosine RNA Modification in the Tumor Immune Microenvironment: Novel Implications for Immunotherapy
por: Guo, Liting, et al.
Publicado: (2021)

N6-methyladenosine reader YTHDF family in biological processes: Structures, roles, and mechanisms
por: Chen, Lin, et al.
Publicado: (2023)

Upregulated N6-Methyladenosine RNA in Peripheral Blood: Potential Diagnostic Biomarker for Breast Cancer
por: Xiao, Han, et al.
Publicado: (2021)

N6-Methyladenosine-Related lncRNAs Are Anticipated Biomarkers for Sarcoma Patients
por: Zhang, Xiaohe, et al.
Publicado: (2022)

N6-Methyladenosine Regulator-Mediated Immue Patterns and Tumor Microenvironment Infiltration Characterization in Glioblastoma
por: Xiong, Wu, et al.
Publicado: (2022)

RNA N1-methyladenosine regulator-mediated methylation modification patterns and heterogeneous signatures in glioma
por: Mao, Meng, et al.
Publicado: (2022)

Emerging Perspectives of RNA N(6)-methyladenosine (m(6)A) Modification on Immunity and Autoimmune Diseases
por: Tang, Lipeng, et al.
Publicado: (2021)

Exploration of Potential Integrated Models of N6-Methyladenosine Immunity in Systemic Lupus Erythematosus by Bioinformatic Analyses
por: Zhao, Xingwang, et al.
Publicado: (2022)

OxLDL promotes lymphangiogenesis and lymphatic metastasis in gastric cancer by upregulating VEGF-C expression and secretion
por: Ma, Caiqi, et al.
Publicado: (2018)

The N(6)-Methyladenosine-Modified Pseudogene HSPA7 Correlates With the Tumor Microenvironment and Predicts the Response to Immune Checkpoint Therapy in Glioblastoma
por: Zhao, Rongrong, et al.
Publicado: (2021)

FUBP1 promotes colorectal cancer stemness and metastasis via DVL1‐mediated activation of Wnt/β‐catenin signaling
por: Yin, Haofan, et al.
Publicado: (2021)

N6-Methyladenosine-Related LncRNAs Are Potential Remodeling Indicators in the Tumor Microenvironment and Prognostic Markers in Osteosarcoma
por: Wu, Zhongguang, et al.
Publicado: (2022)

N6-Methyladenosine-Related Long Noncoding RNAs as Potential Prognosis Biomarkers for Endometrial Cancer
por: Shi, Rui, et al.
Publicado: (2021)

Peripheral Blood Leukocyte N6-methyladenosine is a Noninvasive Biomarker for Non-small-cell Lung Carcinoma
por: Pei, Yuqing, et al.
Publicado: (2020)

N(6)-Methyladenosine-Modified circRNA in the Bovine Mammary Epithelial Cells Injured by Staphylococcus aureus and Escherichia coli
por: Xu, Haojun, et al.
Publicado: (2022)

N(6)-methyladenosine modification of viral RNA and its role during the recognition process of RIG-I-like receptors
por: Li, Huanan, et al.
Publicado: (2022)

Emerging predictive biomarkers for novel therapeutics in peripheral T-cell and natural killer/T-cell lymphoma
por: Yap, Daniel Ren Yi, et al.
Publicado: (2023)

Stabilization of UCA1 by N6-methyladenosine RNA methylation modification promotes colorectal cancer progression
por: He, Rong-Zhang, et al.
Publicado: (2021)

Elevated Peripheral T Helper Cells Are Associated With Atrial Fibrillation in Patients With Rheumatoid Arthritis
por: Wang, Xin, et al.
Publicado: (2021)

N(6)-methyladenosine methyltransferase KIAA1429 elevates colorectal cancer aerobic glycolysis via HK2-dependent manner
por: Li, Ying, et al.
Publicado: (2022)

Links Between N (6)-Methyladenosine and Tumor Microenvironments in Colorectal Cancer
por: Zhang, Yundi, et al.
Publicado: (2022)

Research progress of N6-methyladenosine in colorectal cancer: A review
por: Lin, Yu, et al.
Publicado: (2023)

A Signature of N(6)-methyladenosine Regulator-Related Genes Predicts Prognoses and Immune Responses for Head and Neck Squamous Cell Carcinoma
por: Chen, Junjun, et al.
Publicado: (2022)

Association of Peripheral Blood Biomarkers With Response to Anti-PD-1 Immunotherapy for Patients With Deficient Mismatch Repair Metastatic Colorectal Cancer: A Multicenter Cohort Study
por: Cheng, Yi-Kan, et al.
Publicado: (2022)

Pigment epithelium‐derived factor/vascular endothelial growth factor ratio plays a crucial role in the spontaneous regression of infant hemangioma and in the therapeutic effect of propranolol
por: Zhu, Liuqing, et al.
Publicado: (2018)

The functions of N6-methyladenosine modification in lncRNAs
por: He, Rong-Zhang, et al.
Publicado: (2020)

N6-Methyladenosine-Regulated mRNAs: Potential Prognostic Biomarkers for Patients With Lung Adenocarcinoma
por: Sun, Junjun, et al.
Publicado: (2021)

One Stone, Two Birds: N6-Methyladenosine RNA Modification in Leukemia Stem Cells and the Tumor Immune Microenvironment in Acute Myeloid Leukemia
por: Ouyang, Xianfeng, et al.
Publicado: (2022)

METTL3-Mediated N6-Methyladenosine Modification of Trim59 mRNA Protects Against Sepsis-Induced Acute Respiratory Distress Syndrome
por: Chen, Yi, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_v6dsua9ebbk1sg39p6k14tnhqd